Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • Anti-CALCACGRP Antibody (Fremanezumab)

    2025-09-18

    Anti-CALCA/CGRP Antibody (Fremanezumab)

    Author: ApexBio

    spu:

    F1120

    CAS:

    1655501-53-3

    purity:

    > 95% by SDS-PAGE and SEC-HPLC analyses.

    shortsummary:

    Anti-CALCA/CGRP Antibody (Fremanezumab)

    278779-30-9 site

    M.Wt:

    145 kDa

    Storage:

    -80°C

    DeliveryTime:

    Ship with 3-5 days

    210344-95-9 Description

    ShippingType:

    Dry ice

    description:

    Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide that is involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential to be used in the study of chronic migraine.

    Anti-CALCA/CGRP Antibody (Fremanezumab) PMC10803591

    related websites:

    APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 17444 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.

    https://www.apexbt.com/